Edward R. Ergenzinger
Direct: (919) 794-1655
- Cannabis, Hemp, and CBD
- Commercial Transactions
- Intellectual Property
- North Carolina
- United States Patent & Trademark Office
- Wake Forest University School of Law, JD, 2002
- Wake Forest University, B.A., Biology and Psychology, 1994
- Wake Forest University, Ph.D., Neuroscience, 1999
Large Law Firm Experience:
- Alston & Bird, LLP
Ed is a patent attorney with more than fifteen years of in-house and private practice experience. Over the course of his career he has represented a range of clients, from Fortune 500 companies and world-class research universities to early stage companies and independent inventors.
A substantial portion of Ed’s practice involves the provision of patent services, including the preparation and prosecution of patent applications, strategic planning and management of worldwide patent portfolios, and the preparation of patent-related opinions. His experience encompasses a wide array of technologies, including:
- Agricultural biotechnology;
- Biofuels and biomass conversion;
- Biomanufacturing processes;
- Cell culture systems and media;
- Diagnostic methods and devices;
- Food sciences and safety;
- Gene delivery and therapeutic methods;
- Microfluidic systems for molecular diagnostics and next-generation sequencing;
- Pharmaceuticals and small molecule formulations;
- Recombinant biologicals; and
- Vaccines and immunotherapies.
In addition to patent services, Ed also has substantial experience preparing and prosecuting trademark applications and has counseled non-profit organizations, universities, and artists on trademark and copyright issues. He has also drafted and negotiated a variety of intellectual property related agreements and contract provisions, including sponsored research agreements, collaborative research agreements, material and data transfer agreements, confidentiality agreements, and licensing agreements.
Ed regularly serves as an Adjunct Professor of Law and has taught patent and intellectual property classes at Wake Forest University School of Law, Campbell University School of Law, and University of North Carolina School of Law. He is frequently invited to speak on a variety of legal topics at local, national, and international meetings and programs. Ed has also authored over forty scientific and legal publications that have appeared in such venues as Legal Times, The Scientist, Stanford Technology Law Review, BNA’s Patent Trademark & Copyright Journal, Nature Neuroscience, Nature Biotechnology, and Nature Reviews Neuroscience.
In 1994, Ed received a B.A. in Biology and Psychology, cum laude with honors, from Wake Forest University, where he was a Presidential Scholar for Distinguished Achievement in Music. He received a Ph.D. in Neuroscience from Wake Forest University in 1999, where he was a National Institute of Mental Health Predoctoral Fellow in the Department of Neurosurgery at the School of Medicine. In 2002, he received a J.D. from the Wake Forest University School of Law, where he was the Co-Founder and Editor-in-Chief of the Wake Forest Intellectual Property Law Journal and the recipient of an American Bar Association Award for Excellence in the Study of Intellectual Property Law.
Representative Transactions Include:
- Three years of in-house experience managing all patent and contract matters for the Duke Human Vaccine Institute (DHVI); matters that arose from over $50 million dollars per year of extramural grants and contracts and that involved collaborations with some of the top academic research institutions and largest pharmaceutical companies in the world.
- Provided patent preparation, prosecution, and portfolio management services for a university spin out company prior to and following its acquisition by the world’s leading DNA sequencing company for $96 Million. Over the course of ten years, this university spin out built an impressive patent portfolio directed to digital microfluidics technology to perform complex laboratory protocols.
- Over three years of experience as virtual in-house counsel for the vaccine division of one of the world’s largest pharmaceutical companies. Provided on-site patent counsel services for their North Carolina research and manufacturing facilities, including seminal patent prosecution and worldwide portfolio management services for a multivalent polysaccharide-protein conjugate vaccine that generated sales of over $6 Billion in 2015.
- Provided patent opinion and patent application services for one of the world’s leading agricultural biotechnology companies; work that formed the basis for a joint venture with another of the world’s top agricultural biotechnology companies to commercialize soybeans with a stacked trait that confers tolerance to three herbicide active ingredients.